Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Sowa, Jan Peter ^a   Atmaca, Özgür ^a,b   Kahraman, Alisan ^a   Schlattjan, Martin ^a   Lindner, Marion ^c   Sydor, Svenja ^a   Scherbaum, Norbert ^c   Lackner, Karoline ^d   Gerken, Guido ^a   Heider, Dominik ^e   Arteel, Gavin E ^f   Erim, Yesim ^c,g   Canbay, Ali ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f University of Louisville School of Medicine   (United States)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKERATIN 18; HYALURONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; CYTOKINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DECISION TREE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RANDOM FOREST; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; ARTIFICIAL INTELLIGENCE; BIOLOGICAL MODEL; BLOOD; COHORT ANALYSIS; COMPUTER SIMULATION; FATTY LIVER, ALCOHOLIC; LIVER; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ADIPOKINES; ADIPONECTIN; ALANINE TRANSAMINASE; ARTIFICIAL INTELLIGENCE; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; COMPUTER SIMULATION; CYTOKINES; FATTY LIVER, ALCOHOLIC; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NON-ALCOHOLIC FATTY LIVER DISEASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903779803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101444     Document Type: Article

References (24)

1. Bhala N, Jouness RIK, Bugianesi E (2013) Epidemiology and natural history of patients with NAFLD. Curr. Pharm. Des. 19: 5169-5176.
2. Zakhari S, Li T-K (2007) Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology 46: 2032-2039.
3. Erim Y, Beckmann M, Tagay S, Beckebaum S, Gerken G, et al. (2006) [Stabilisation of abstinence by means of psychoeducation for patients with alcoholic liver disease awaiting liver transplantation]. Z Psychosom Med Psychother 52: 341-357.
4. Cello JP, Rogers SJ (2013) Morbid obesity-the new pandemic: medical and surgical management, and implications for the practicing gastroenterologist. Clin Transl Gastroenterol 4: e35.
5. Ertle J, Dechêne A, Sowa J-P, Penndorf V, Herzer K, et al. (2011) Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int. J. Cancer 128: 2436-2443.
6. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, et al. (2012) Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J. Hepatol. 57: 384-391.
7. Ruhl CE, Everhart JE (2005) Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin. Gastroenterol. Hepatol. 3: 1260-1268. (Pubitemid 41797679)
8. Erim Y, Böttcher M, Dahmen U, Beck O, Broelsch CE, et al. (2007) Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation. Liver Transpl. 13: 757-761. (Pubitemid 46796549)
9. Meyer D, Leisch F, Hornik K (2003) The support vector machine under test. Neurocomputing 55: 169-186. (Pubitemid 37336675)
10. Breiman L (2001) Random Forests. Machine Learning 45: 5-32.
11. Cawley GC, Talbot NLC (2004) Fast exact leave-one-out cross-validation of sparse least-squares support vector machines. Neural Netw 17: 1467-1475. (Pubitemid 39487142)
12. Fawcett T (2006) An introduction to ROC analysis. Pattern Recognit. Lett. 27: 861-874.
13. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: visualizing classifier performance in R. Bioinformatics 21: 3940-3941. (Pubitemid 41535515)
14. Cohen JA, Kaplan MM (1979) The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig. Dis. Sci. 24: 835-838. (Pubitemid 10217942)
15. Kramer G, Erdal H, Mertens HJMM, Nap M, Mauermann J, et al. (2004) Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 64: 1751-1756. (Pubitemid 38428698)
16. Frébourg T, Delpech B, Bercoff E, Senant J, Bertrand P, et al. (1986) Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 6: 392-395. (Pubitemid 16086624)
17. Guéchot J, Poupon RE, Poupon R (1995) Serum hyaluronan as a marker of liver fibrosis. J. Hepatol. 22: 103-106.
18. Wedemeyer I, Bechmann LP, Odenthal M, Jochum C, Marquitan G, et al. (2009) Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C. J. Hepatol 50: 140-149.
19. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, et al. (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 56: 952-964.
20. Sagir A, Erhardt A, Schmitt M, Häussinger D (2008) Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47: 592-595. (Pubitemid 351280727)
21. Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, et al. (2009) Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. Ann Hepatol 8: 89-94.
22. Sowa J-P, Heider D, Bechmann LP, Gerken G, Hoffmann D, et al. (2013) Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD. PLoS ONE 8: e62439.
23. Beier JI, Arteel GE (2012) Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism. Exp. Biol. Med. (Maywood) 237: 1-9.
24. Verrijken A, Francque S, Mertens I, Prawitt J, Caron S, et al. (2014) Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 59: 121-129.